Skip to main content
Premium Trial:

Request an Annual Quote

Gene Network Sciences to Help Murex Develop Cancer Drugs

NEW YORK, June 2 (GenomeWeb News) - Gene Network Sciences will help Murex Pharmaceuticals co-develop cancer therapeutics, Murex said yesterday.


GNS uses computer models to study cancer therapies and Murex will use its technology to create computer-based models to help it identify and validate cancer targets. Murex will then design shRNA-based vaccines that halt cancer growth.


GNS scientists will work directly with Murex teams at Murex's research and development facilities in Texas.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.